Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Ann Hum Genet. 2010 Jul;74(4):308–315. doi: 10.1111/j.1469-1809.2010.00589.x

Table 1.

Characteristics of the sample by gender and T2D status.

Variable Gender T2D Status N Mean SD Minimum Median Maximum
Age (yrs) Male Affected 388 54.12 11.90 19 54 92
Unaffected 109 50.33 16.35 18 49 90
Female Affected 778 54.48 12.10 20 55 96
Unaffected 166 51.06 15.60 20 51 95
BMI(kg/m2) Male Affected 378 30.58 6.01 16.75 29.89 55.27
Unaffected 109 28.31 6.21 17.86 27.77 55.90
Female Affected 753 34.43 7.97 16.84 33.30 64.51
Unaffected 155 33.03 7.91 17.28 32.65 55.93
WHR (%) Male Affected 319 97.45 7.78 78.99 96.82 138.33
Unaffected 89 91.99 7.30 77.14 91.48 125.95
Female Affected 701 93.46 10.14 54.37 92.61 137.31
Unaffected 136 87.85 9.36 66.47 87.25 127.38
TC (mg/dL) Male Affected 361 194.26 47.47 62 189 407
Unaffected 105 186.75 38.70 103 188 300
Female Affected 718 194.44 44.51 43 192.5 396
Unaffected 156 187.04 39.21 92 188.5 290
LDL-C (mg/dL) Male Affected 343 126.36 40.83 31 124 316
Unaffected 105 127.08 36.73 48 127.8 237.8
Female Affected 705 124.95 38.33 27 123 328
Unaffected 155 121.51 37.63 29.2 124 217
HDL-C (mg/dL) Male Affected 361 40.24 11.94 14 39 82
Unaffected 105 43.59 13.54 20 42 102
Female Affected 718 47.11 14.51 9 45 111
Unaffected 156 49.76 12.72 25 49 113
TG (mg/dL) Male Affected 361 146.06 148.41 30 106 1432
Unaffected 105 80.52 41.51 24 67 207
Female Affected 718 114.62 86.30 19 90 932
Unaffected 156 78.58 56.79 16 66 521
HHS Vulnerability Disclosure